How safe is your DNA?
By Anne Marie Green,
CBS News
| 04. 15. 2017
A new high-tech, controversial law enforcement procedure has some people worried it threatens the privacy of our DNA
I first learned about the 20-year-old murder of Angie Dodge in a roundabout way, after getting my DNA analyzed by one of those commercial DNA databases. When I got my results back I was not surprised. There were no big revelations and, just as I suspected, I am not related to royalty. But I did wonder if I could learn anything more from the DNA report. That search sent me down a rabbit hole that lead me to the story of Michael Usry Jr., a young filmmaker who became a suspect in the Angie Dodge murder investigation.
After getting my DNA report I learned that there are a number of genealogy sites, educational institutions and companies that are willing to offer you further insight into what your DNA may reveal, as long as you’re willing to upload your DNA profile to them. Some of these sites charge money, while others are simply willing to analyze your DNA profile in exchange for adding...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...